CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr. 23, 2013--
Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will
report its first quarter 2013 financial results on Tuesday, May 7, 2013,
before the market opens. Following the announcement, at 8:30 a.m.
Eastern Time, company management will host a conference call and webcast
discussion of the results and provide a general corporate update.
The live webcast can be accessed by visiting the investor relations
section of the Company’s website at http://investor.ariad.com.
The call can be accessed by dialing 866- 515-2914 (domestic) or
617-399-5128 (international) five minutes prior to the start time and
providing the pass code 43738421. A replay of the call will be available
on the ARIAD website approximately two hours after completion of the
call and will be archived for three weeks.
ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts
and Lausanne, Switzerland, is an integrated global oncology company
focused on transforming the lives of cancer patients with breakthrough
medicines. ARIAD is working on new medicines to advance the treatment of
various forms of chronic and acute leukemia, lung cancer and other
difficult-to-treat cancers. ARIAD utilizes computational and structural
approaches to design small-molecule drugs that overcome resistance to
existing cancer medicines. For additional information, visit http://www.ariad.com
or follow ARIAD on Twitter (@ARIADPharm).
Source: ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc.
Liza Heapes, 617-621-2315